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The high prevalence rate of the drug and 
alcohol-related problems highlights the pub-
lic health importance of this disorder. The 
abuses of legal and illegal drugs remain one 
of the major medical problems in the world 
today. The total number of drug users in the 
world is now estimated at about 200 million 
people, equivalent to about ﬁ  ve percent of 
the global population age 15–64 (United 
Nations Ofﬁ  ce on Drugs and Crime. World 
Drug Report, 2006). Cannabis remains by 
far the most widely used drug, followed by 
amphetamine-type stimulants, opiate and 
cocaine users. Alcohol abuse and alcoholism 
affects nearly 10% of the general popula-
tion both in the United States (McGinnis 
and Foege, 1993) and in Europe (Hupkens 
et al., 1993).
Drug and alcohol abuse have many 
medical consequences. Health effects may 
range between cardiomyopathies, immune 
impairment, endocrine disorders, metabolic 
and nutritional disorders, liver and gastroin-
testinal diseases, cancer disease, neuropsy-
chiatric complications to name a few, so all 
kinds of physicians could be involved in 
the management of these patients. Medical 
approaches continue to develop with new 
discoveries in pharmacology, molecular 
genetics, and immunology.
Indeed, in the last three decades, our 
increased knowledge about the molecular, 
biological and behavioral aspects of addic-
tion has enabled us to improve the man-
agement and survival of these patients. For 
example, the discovery of the neurobiologi-
cal basis of addiction and of different neu-
ral pathways involved in drug and alcohol 
abuse led to identify new pharmacological 
approaches to treatment that can be paired 
with psychosocial treatments. Furthermore, 
there are new advances in pharmacogenetics 
that can bring forward to era of personalized 
medicine to the addictions ﬁ  eld. New vistas 
in vaccine research also promise to improve 
both the prevention and treatment of addic-
tive disorders. All this scientiﬁ  c progress was, 
and shall continue to be, possible due to the 
rapid expansion of research in the ﬁ  eld.
Frontiers in Addictive Disorders will be 
at the cutting-edge of publishing papers 
that will shape our understanding and the 
treatment of addictive diseases now and in 
the future. The scope of the journal is very 
broad and ranges from the laboratory bench 
to society.
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